Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Get Free Report) saw a large drop in short interest in the month of September. As of September 15th, there was short interest totaling 988 shares, a drop of 54.1% from the August 31st total of 2,153 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 48,134 shares, the short-interest ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings initiated coverage on Healthcare Capital Acquisition in a research report on Monday, August 24th. They issued a “sell (e+)” rating for the company. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Healthcare Capital Acquisition currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on Healthcare Capital Acquisition
Healthcare Capital Acquisition Price Performance
Institutional Trading of Healthcare Capital Acquisition
An institutional investor recently bought a new stake in Healthcare Capital Acquisition stock. BlueCrest Capital Management Ltd purchased a new stake in Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 250,000 shares of the company’s stock, valued at approximately $2,510,000. BlueCrest Capital Management Ltd owned 0.67% of Healthcare Capital Acquisition at the end of the most recent reporting period. Institutional investors and hedge funds own 66.82% of the company’s stock.
Healthcare Capital Acquisition Company Profile
Healthcare Capital Acquisition Corp. (NASDAQ: HCAC) was a special purpose acquisition company (SPAC) formed to pursue a business combination with a company in the healthcare industry. As a blank-check company, it did not operate a healthcare business or offer its own products and services.
Its investment focus was broadly oriented toward healthcare, life sciences, medical technology, pharmaceuticals, biotechnology, diagnostics and related sectors. The company’s principal activity was identifying a suitable target, negotiating a transaction and obtaining approval from its shareholders and other stakeholders.
Because Healthcare Capital Acquisition Corp.
See Also
- Five stocks we like better than Healthcare Capital Acquisition
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
- 2 China-Focused ETFs For After the Trump-Xi Summit
Receive News & Ratings for Healthcare Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
